Heineken warns UK pubs weight loss drugs could reduce beer sales

Heineken has warned British bars and pubs that the rising popularity of weight loss drugs could lead to a fall in sales of beer and cider, according to the Guardian. The document was revealed by Reuters. [1]

The Guardian reported that the world's second largest brewer sent a presentation to British hospitality customers earlier this month. The document said that GLP-1 medications, such as Ozempic and Wegovy, can reduce the desire to drink alcohol. Heineken warned that this trend could result in fullness and fewer serves of pints in venues. [1]

Low alcohol beer, also known as light beer or non-alcoholic beer, reproduces the taste of beer while eliminating or reducing the inebriating effect, carbohydrates, and calories of regular alcoholic brews. Heineken operates production facilities including breweries in more than 70 countries and distributes over 300 brands across 190 markets. [2][3]